Abstract
A score based on the combination of the systemic inflammatory response and albumin hazards ratio (HR) 1.70, 95% CI 1.23 - 2.35, P=0.001) was comparable in prognostic value to that based on stage and performance status (HR 1.48, 95% CI 1.12 - 1.95, P=0.006) in patients with inoperable non-small-cell lung cancer. The former is simple to measure and well standardised.
MeSH terms
-
Adenocarcinoma / blood
-
Adenocarcinoma / diagnosis
-
Albumins / analysis*
-
Biomarkers, Tumor / analysis*
-
C-Reactive Protein / analysis*
-
Carcinoma, Non-Small-Cell Lung / blood
-
Carcinoma, Non-Small-Cell Lung / diagnosis*
-
Carcinoma, Squamous Cell / blood
-
Carcinoma, Squamous Cell / diagnosis
-
Female
-
Humans
-
Hypoalbuminemia / complications
-
Inflammation
-
Karnofsky Performance Status
-
Lung Neoplasms / blood
-
Lung Neoplasms / diagnosis*
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Prognosis
-
Prospective Studies
-
Retrospective Studies
Substances
-
Albumins
-
Biomarkers, Tumor
-
C-Reactive Protein